Corrigendum: SCD1 Confers Temozolomide Resistance to Human Glioma Cells Via the Akt/GSK3β/β-Catenin Signaling Axis - Dai, Shuang; Yan, Yuanliang; Xu, Zhijie; Zeng, Shuangshuang; Qian, Long; Huo, Lei; Li, Xuejun; Sun, Lunquan; Gong, Zhicheng (Frontiers in Pharmacology, 2019)